A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Clinical trial NCT01938625 · COMPLETED
Trial details
- NCT number
- NCT01938625
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-12
- Primary completion
- 2015-04-27
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.